Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients

Phase 1

Conditions: Triple Negative Breast Cancer

Interventions: Combination Product: JS001 120mg+GP
Combination Product: GP followed by JS001
Combination Product: JS001 240mg+GP
Combination Product: JS001 480mg+GP

First Posted Date: 2017-08-16

Last Posted Date: 2022-04-20

Lead Sponsor: Fudan University

Target Recruit Count: 31

Registration Number: NCT03251313

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery

Not Applicable

Conditions: Cancer of Pancreas

Interventions: Drug: GEA
Drug: GA
Drug: PCIA
Drug: PCEA

First Posted Date: 2017-08-10

Last Posted Date: 2019-12-11

Lead Sponsor: Fudan University

Target Recruit Count: 540

Registration Number: NCT03245346

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
🇨🇳
Fudan University Huashan Hospital, Shanghai, Shanghai, China
🇨🇳
Fudan University Zhongshan Hospital, Shanghai, Shanghai, China

PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)

Completed

Conditions: Esophageal Cancer

First Posted Date: 2017-08-09

Last Posted Date: 2023-07-13

Lead Sponsor: Fudan University

Target Recruit Count: 110

Registration Number: NCT03244566

Locations: 🇨🇳
Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China
🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
🇨🇳
Jiangdu people's hospital of Yangzhou, Yangzhou, Jiangsu, China

and more 1 locations

Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer

Phase 2

Completed

Conditions: Endometrial Neoplasm Malignant Stage I

Interventions: Drug: Megestrol Acetate
Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS)

First Posted Date: 2017-08-08

Last Posted Date: 2020-11-20

Lead Sponsor: Fudan University

Target Recruit Count: 64

Registration Number: NCT03241914

Locations: 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Phase 2

Completed

Conditions: Atypical Endometrial Hyperplasia

Interventions: Device: Levonorgestrel-releasing Intrauterine System(LNG-IUS)
Drug: Megestrol Acetate

First Posted Date: 2017-08-08

Last Posted Date: 2020-06-18

Lead Sponsor: Fudan University

Target Recruit Count: 180

Registration Number: NCT03241888

Locations: 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China

Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)

Completed

Conditions: Non-small Cell Lung Cancer Stage I
Lymph Node Metastases

Interventions: Diagnostic Test: Intra-operative frozen section

First Posted Date: 2017-07-13

Last Posted Date: 2023-07-20

Lead Sponsor: Fudan University

Target Recruit Count: 1076

Registration Number: NCT03216551

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer

Phase 2

Conditions: Breast Neoplasms

Interventions: Drug: Fulvestrant

First Posted Date: 2017-06-29

Last Posted Date: 2017-06-29

Lead Sponsor: Fudan University

Target Recruit Count: 50

Registration Number: NCT03202862

Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis

Phase 4

Recruiting

Conditions: Non-alcoholic Steatohepatitis

Interventions: Behavioral: Lifestyle intervention
Drug: Placebo
Drug: Berberine

First Posted Date: 2017-06-26

Last Posted Date: 2023-08-08

Lead Sponsor: Fudan University

Target Recruit Count: 120

Registration Number: NCT03198572

Locations: 🇨🇳
Department of Endocrinology and Metabolism,Shanghai 6th People's Hospital, Shanghai, Shanghai, China
🇨🇳
The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China
🇨🇳
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

and more 3 locations

Case-control Study on Individual Risk Factors of CTS

Completed

Conditions: Carpal Tunnel Syndrome

Interventions: Other: the disease

First Posted Date: 2017-05-24

Last Posted Date: 2017-05-24

Lead Sponsor: Fudan University

Target Recruit Count: 6048

Registration Number: NCT03166033

Locations: 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer

Phase 1

Conditions: Metastatic Breast Cancer

Interventions: Radiation: stereotactic body radiation therapy

First Posted Date: 2017-05-12

Last Posted Date: 2017-05-12

Lead Sponsor: Fudan University

Target Recruit Count: 18

Registration Number: NCT03151447

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy